본문 바로가기
KERD
논문KCI 등재

Fluid management in perioperative and critically ill patients

Dongho Kang|Kyung Yeon Yoo
대한중환자의학회 (The Korean Society Of Critical Care Medicine)|2019.11|Acute and Critical Care|제34권 제4호|pp. 235-245|DOI https://doi.org/10.4266/acc.2019.00717

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

colloidsfluid therapyintensive careglycocalyxcrystalloid solutions

초록

Fluid therapy to restore and/or maintain tissue perfusion may affect patient outcomes in perioperative, emergency, and intensive care. Kinetic analyses and outcome-oriented studies have provided more insight into fluid management. Crystalloids are slowly distributed to the interstitial space, and the efficiency (proportion of infused fluid retained in the bloodstream) is 50%−75% as long as infusion continues and may increase up to 100% when the arterial pressure has decreased. Elimination of the infused fluid during general anesthesia and surgery is very slow, amounting to only 10%–20% compared with that in conscious patients. When the endothelial glycocalyx layer is degraded in sepsis or trauma-induced systemic inflammation, turnover of colloids and crystalloids is accelerated and the efficiency is reduced, which may lead to tissue edema, inflammation, poor wound healing, and organ dysfunction. Balanced crystalloids are pragmatic initial resuscitation fluids and improve patient outcomes compared to saline (0.9% sodium chloride). Albumin may be beneficial, but other synthetic colloids appear to increase the risk of acute kidney injury and death among patients in the intensive care unit. Fluid kinetics is likely to change based on patient physiological conditions (e.g., general anesthesia, surgery, stress, dehydration, blood pressure, or inflammation) and fluid types. To maximize efficacy and minimize iatrogenic side effects, fluids should be prescribed based on individual patient factors, disease states, and other treatment remedies.

Abstract

Fluid therapy to restore and/or maintain tissue perfusion may affect patient outcomes in perioperative, emergency, and intensive care. Kinetic analyses and outcome-oriented studies have provided more insight into fluid management. Crystalloids are slowly distributed to the interstitial space, and the efficiency (proportion of infused fluid retained in the bloodstream) is 50%−75% as long as infusion continues and may increase up to 100% when the arterial pressure has decreased. Elimination of the infused fluid during general anesthesia and surgery is very slow, amounting to only 10%–20% compared with that in conscious patients. When the endothelial glycocalyx layer is degraded in sepsis or trauma-induced systemic inflammation, turnover of colloids and crystalloids is accelerated and the efficiency is reduced, which may lead to tissue edema, inflammation, poor wound healing, and organ dysfunction. Balanced crystalloids are pragmatic initial resuscitation fluids and improve patient outcomes compared to saline (0.9% sodium chloride). Albumin may be beneficial, but other synthetic colloids appear to increase the risk of acute kidney injury and death among patients in the intensive care unit. Fluid kinetics is likely to change based on patient physiological conditions (e.g., general anesthesia, surgery, stress, dehydration, blood pressure, or inflammation) and fluid types. To maximize efficacy and minimize iatrogenic side effects, fluids should be prescribed based on individual patient factors, disease states, and other treatment remedies.

참고문헌 (78)

  1. Connolly CM, "Isoflurane but not mechanical ventilation promotes extravascular fluid accumulation during crystalloid volume loading", Anesthesiology, 98, pp.670~681 (2003)
  2. Zdolsek J, "Detection of dehydration by using volume kinetics", Anesth Analg, 115, pp.814~822 (2012)
  3. Drobin D, "Volume kinetics of Ringer’s solution in hypovolemic volunteers", Anesthesiology, 90, pp.81~91 (1999)
  4. Hahn RG, "Arterial pressure and the rate of elimination of crystalloid fluid", Anesth Analg, 124, pp.1824~1833 (2017)
  5. Hahn RG, "The half-life of infusion fluids : an educational review", Eur J Anaesthesiol, 33, pp.475~482 (2016)
  6. Olsson J, "The volume kinetics of acetated Ringer’s solution during laparoscopic cholecystectomy", Anesth Analg, 99, pp.1854~1860 (2004)
  7. Hahn RG, "Why are crystalloid and colloid fluid requirements similar during surgery and intensive care?", Eur J Anaesthesiol, 30, pp.515~518 (2013)
  8. Hahn RG, "Why crystalloids will do the job in the operating room", Anaesthesiol Intensive Ther, 46, pp.342~349 (2014)
  9. Hahn RG, "Volume kinetics for infusion fluids", Anesthesiology, 113, pp.470~481 (2010)
  10. Semler MW, "Balanced crystalloids versus saline in critically ill adults", N Engl J Med, 378, pp.829~839 (2018)
  11. Self WH, "Balanced crystalloids versus saline in noncritically ill adults", N Engl J Med, 378, pp.819~828 (2018)
  12. Apfel CC, "Supplemental intravenous crystalloids for the prevention of postoperative nausea and vomiting : quantitative review", Br J Anaesth, 108, pp.893~902 (2012)
  13. Holte K, "Compensatory fluid administration for preoperative dehydration: does it improve outcome?", Acta Anaesthesiol Scand, 46, pp.1089~1093 (2002)
  14. Raghunathan K, "Association between initial fluid choice and subsequent in-hospital mortality during the resuscitation of adults with septic shock", Anesthesiology, 123, pp.1385~1393 (2015)
  15. Alphonsus CS, "The endothelial glycocalyx : a review of the vascular barrier", Anaesthesia, 69, pp.777~784 (2014)
  16. Kolsen-Petersen JA, "The endothelial glycocalyx : the great luminal barrier", Acta Anaesthesiol Scand, 59, pp.137~139 (2015)
  17. Chappell D, "Role of the glycocalyx in fluid management : small things matter", Best Pract Res Clin Anaesthesiol, 28, pp.227~234 (2014)
  18. Uchimido R, "The glycocalyx : a novel diagnostic and therapeutic target in sepsis", Crit Care, 23, pp.16~ (2019)
  19. Fleck A, "Increased vascular permeability : a major cause of hypoalbuminaemia in disease and injury", Lancet, 1, pp.781~784 (1985)
  20. McFarlane C, "A comparison of Plasmalyte 148 and 0.9%saline for intra-operative fluid replacement", Anaesthesia, 49, pp.779~781 (1994)
  21. Scheingraber S, "Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery", Anesthesiology, 90, pp.1265~1270 (1999)
  22. McLean DJ, "Intravenous fluids : effects on renal outcomes", Br J Anaesth, 120, pp.397~402 (2018)
  23. Semler MW, "Saline is not the first choice for crystalloid resuscitation fluids", Crit Care Med, 44, pp.1541~1544 (2016)
  24. Yunos NM, "Chloride-liberal vs. chloride-restrictive intravenous fluid administration and acute kidney injury: an extended analysis", Intensive Care Med, 41, pp.257~264 (2015)
  25. Boer C, "Choice of fluid type : physiological concepts and perioperative indications", Br J Anaesth, 120, pp.384~396 (2018)
  26. Haase N, "Hydroxyethyl starch 130", 0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis, 2013, pp.346, f839~
  27. Gattas DJ, "Fluid resuscitation with 6 % hydroxyethyl starch (130", 0.4 and 130, Intensive Care Med, pp.2013, 39[DOI]
  28. Kammerer T, "No differences in renal function between balanced 6%hydroxyethyl starch (130", 0.4) and 5% albumin for volume replacement therapy in patients undergoing cystectomy: a randomized controlled trial, 2018, pp.128, 67~78
  29. Kabon B, "Effect of intraoperative goal-directed balanced crystalloid versus colloid administration on major postoperative morbidity : a randomized trial", Anesthesiology, 130, pp.728~744 (2019)
  30. Rehm M, "Changes in blood volume and hematocrit during acute preoperative volume loading with 5% albumin or 6% hetastarch solutions in patients before radical hysterectomy", Anesthesiology, 95, pp.849~856 (2001)
  31. Levick JR, "Microvascular fluid exchange and the revised Starling principle", Cardiovasc Res, 87, pp.198~210 (2010)
  32. Starling EH, "On the absorption of fluids from the connective tissue spaces", J Physiol, 19, pp.312~326 (1896)
  33. Adamson RH, "Oncotic pressures opposing filtration across nonfenestrated rat microvessels", J Physiol, 557(Pt 3), pp.889~907 (2004)
  34. Woodcock TE, "Revised Starling equation and the glycocalyx model of transvascular fluid exchange : an improved paradigm for prescribing intravenous fluid therapy", Br J Anaesth, 108, pp.384~394 (2012)
  35. Hall JE, "Guyton and Hall textbook of medical physiology", pp.305~321 (2016), Elsevier
  36. Drobin D, "Kinetics of isotonic and hypertonic plasma volume expanders", Anesthesiology, 96, pp.1371~1380 (2002)
  37. Reid F, "(Ab)normal saline and physiological Hartmann’s solution: a randomized double-blind crossover study", Clin Sci (Lond), 104, pp.17~24 (2003)
  38. Sjöstrand F, "Volume kinetics of glucose solutions given by intravenous infusion", Br J Anaesth, 87, pp.834~843 (2001)
  39. Wilcox CS, "Regulation of renal blood flow by plasma chloride", J Clin Invest, 71, pp.726~735 (1983)
  40. Hahn RG, "The elimination half-life of crystalloid fluid is shorter in female than in male volunteers : a retrospective population kinetic analysis", Biol Sex Differ, 7, pp.54~ (2016)
  41. Lobo DN, "Effect of volume loading with 1 liter intravenous infusions of 0.9% saline, 4% succinylated gelatine (Gelofusine)and 6% hydroxyethyl starch (Voluven) on blood volume and endocrine responses: a randomized, three-way crossover study in healthy volunteers", Crit Care Med, 38, pp.464~470 (2010)
  42. Holte K, "Influence of “liberal” versus “restrictive” intraoperative fluid administration on elimination of a postoperative fluid load", Anesthesiology, 106, pp.75~79 (2007)
  43. Brandstrup B, "Effects of intravenous fluid restriction on postoperative complications : comparison of two perioperative fluid regimens : a randomized assessor-blinded multicenter trial", Ann Surg, 238, pp.641~648 (2003)
  44. Hahn RG, "Distribution of crystalloid fluid changes with the rate of infusion : a population-based study", Acta Anaesthesiol Scand, 60, pp.569~578 (2016)
  45. Hahn RG, "Volume kinetics of acetated Ringer’s solution during experimental spinal anaesthesia", Acta Anaesthesiol Scand, 55, pp.987~994 (2011)
  46. Ewaldsson CA, "Volume kinetics of Ringer’s solution during induction of spinal and general anaesthesia", Br J Anaesth, 87, pp.406~414 (2001)
  47. Chowdhury AH, "A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte® 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers", Ann Surg, 256, pp.18~24 (2012)
  48. Shaw AD, "Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte", Ann Surg, 255, pp.821~829 (2012)
  49. Chua HR, "Plasma-Lyte 148 vs 0.9% saline for fluid resuscitation in diabetic ketoacidosis", J Crit Care, 27, pp.138~145 (2012)
  50. Rhodes A, "Surviving Sepsis Campaign : International Guidelines for Management of Sepsis and Septic Shock : 2016", Intensive Care Med, 43, pp.304~377 (2017)
  51. Brunkhorst FM, "Intensive insulin therapy and pentastarch resuscitation in severe sepsis", N Engl J Med, 358, pp.125~139 (2008)
  52. Joosten A, "Crystalloid versus colloid for intraoperative goal-directed fluid therapy using a closed-loop system : a randomized, double-blinded, controlled trial in major abdominal surgery", Anesthesiology, 128, pp.55~66 (2018)
  53. Hahn RG, "Adverse effects of crystalloid and colloid fluids", Anaesthesiol Intensive Ther, 49, pp.303~308 (2017)
  54. Reuter DA, "The dark sides of fluid administration in the critically ill patient", Intensive Care Med, 44, pp.1138~1140 (2018)
  55. Vincent JL, "Fluid management in the critically ill", Kidney Int, 96, pp.52~57 (2019)
  56. Brandstrup B, "Hemorrhage and operation cause a contraction of the extracellular space needing replacement : evidence and implications? : a systematic review", Surgery, 139, pp.419~432 (2006)
  57. Varadhan KK, "A meta-analysis of randomised controlled trials of intravenous fluid therapy in major elective open abdominal surgery : getting the balance right", Proc Nutr Soc, 69, pp.488~498 (2010)
  58. Ewaldsson CA, "Kinetics and extravascular retention of acetated ringer’s solution during isoflurane or propofol anesthesia for thyroid surgery", Anesthesiology, 103, pp.460~469 (2005)
  59. Glatz T, "Postoperative fluid overload is a risk factor for adverse surgical outcome in patients undergoing esophagectomy for esophageal cancer : a retrospective study in 335 patients", BMC Surg, 17, pp.6~ (2017)
  60. Myles PS, "Restrictive versus liberal fluid therapy for major abdominal surgery", N Engl J Med, 378, pp.2263~2274 (2018)
  61. Myles PS, "Importance of intraoperative oliguria during major abdominal surgery : findings of the restrictive versus liberal fluid therapy in major abdominal surgery trial", Br J Anaesth, 122, pp.726~733 (2019)
  62. Jalil BA, "Predicting fluid responsiveness : a review of literature and a guide for the clinician", Am J Emerg Med, 36, pp.2093~2102 (2018)
  63. Holte K, "Liberal versus restrictive fluid administration to improve recovery after laparoscopic cholecystectomy : a randomized, double-blind study", Ann Surg, 240, pp.892~899 (2004)
  64. Holte K, "Liberal versus restrictive fluid management in knee arthroplasty : a randomized, double-blind study", Anesth Analg, 105, pp.465~474 (2007)
  65. Wu Y, "Effects of intraoperative fluid management on postoperative outcomes after lobectomy", Ann Thorac Surg, 107, pp.1663~1669 (2019)
  66. Malbrain ML, "Principles of fluid management and stewardship in septic shock : it is time to consider the four D’s and the four phases of fluid therapy", Ann Intensive Care, 8, pp.66~ (2018)
  67. Casey JD, "Resuscitation fluids", Curr Opin Crit Care, 24, pp.512~518 (2018)
  68. Rivers E, "Early goal-directed therapy in the treatment of severe sepsis and septic shock", N Engl J Med, 345, pp.1368~1377 (2001)
  69. Marik PE, "Iatrogenic salt water drowning and the hazards of a high central venous pressure", Ann Intensive Care, 4, pp.21~ (2014)
  70. Mouncey PR, "Trial of early, goal-directed resuscitation for septic shock", N Engl J Med, 372, pp.1301~1311 (2015)
  71. ARISE Investigators, "Goal-directed resuscitation for patients with early septic shock", N Engl J Med, 371, pp.1496~1506 (2014)
  72. ProCESS Investigators, "A randomized trial of protocolbased care for early septic shock", N Engl J Med, 370, pp.1683~1693 (2014)
  73. Levy MM, "The Surviving Sepsis Campaign Bundle : 2018 update", Intensive Care Med, 44, pp.925~928 (2018)
  74. Corl KA, "The restrictive IV fluid trial in severe sepsis and septic shock(RIFTS) : a randomized pilot study", Crit Care Med, 47, pp.951~959 (2019)
  75. Brown RM, "Fluid management in sepsis", J Intensive Care Med, 34, pp.364~373 (2019)
  76. Li Y, "Ringer’s lactate, but not hydroxyethyl starch, prolongs the food intolerance time after major abdominal surgery; an open-labelled clinical trial", BMC Anesthesiol, 15, pp.72~ (2015)
  77. Hahn RG, "Interactions between the volume effects of hydroxyethyl starch 130", 0.4 and Ringer’s acetate, 2013, pp.17, R104~
  78. Hippensteel JA, "Intravenous fluid resuscitation is associated with septic endothelial glycocalyx degradation", Crit Care, 23, pp.259~ (2019)

이 간행물의 다른 논문 (8건)

Effect of a rapid response system on code rates and in-hospital mortality in medical wards이진우, 류호걸, 조재영, 양은진, Sang-Min Lee, Hannah Lee, Hyun Joo Lee, Sang-Bae Ko, Hong Yeul Lee, Sulhee Kim, Seung-Young Oh, Eun Jin Happ. 246-254The association between the initial lactate level and need for massive transfusion in severe trauma patients with and without traumatic brain injury이병국, Young Hoon Park, Dong Hyun Ryu, Dong Hun Leepp. 255-262How small is enough for the left heart decompression cannula during extracorporeal membrane oxygenation?김진석, Sua Kim, Jae Seung Shin, Hong Ju Shinpp. 263-268Risk factor, monitoring, and treatment for snakebite induced coagulopathy: a multicenter retrospective study신동우, Jong Wan Kim, Yong Jun Jeon, Sung Gil Parkpp. 269-275Lund and Browder chart—modified versus original: a comparative studyArun Murar, Kaushal Neelam Singhpp. 276-281
원문 보기